Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Field Cancerization Therapies: Medical Dermatology and Beyond
Description
The presentation discusses the European approach to photodynamic therapy (PDT) for treating actinic keratosis and field cancerization, emphasizing the importance of understanding the underlying pathophysiology of skin lesions caused by prolonged UV exposure. The speaker notes the increasing recognition of these conditions as significant health concerns, potentially leading to squamous cell carcinoma. Various treatment modalities are evaluated, including the effectiveness of topical therapies, surgical interventions, and the innovative daylight PDT, which avoids pain and allows for larger treatment areas. Emerging therapies, such as turbinibulin and the HPV vaccine, hold promise for improving patient outcomes and prevention strategies. The discourse also highlights the necessity for individualized treatment plans that consider patient preferences and the impact of side effects, particularly for older patients. The key takeaway is a shift towards ongoing management of skin cancer, advocating for patient-centered care in dermatology.
View moreConclusions
- Photodynamic therapy demonstrates selectivity and efficacy in treating actinic keratosis and field cancerization.
- Field cancerization is a key factor in the development of new actinic keratoses, indicating the need for proactive treatment strategies.
- Treatment should be patient-centered, considering individual conditions, locations of lesions, and patient preferences.
- Combining therapies, such as topical agents with photodynamic therapy, may enhance treatment outcomes in actinic keratosis patients.
- Early intervention is critical for lesions showing signs of potential progression to squamous cell carcinoma.
- Understanding the pathophysiology and risk factors is essential for effective management and treatment of actinic keratosis.
- New therapeutic options, including chemoprevention and immunization strategies, could be considered for better management of high-risk patients.
- Ongoing patient education and follow-up are vital for preventing recurrence of actinic keratoses.
- Kandolf L et al. (2024) European consensus-based interdisciplinary guideline for diagnosis, treatment and prevention of actinic keratoses, epithelial UV-induced dysplasia and field cancerization. J Eur Acad Dermatol Venereol 38:1024-1047
- Nazzaro G et al. Efficacy and tolerability of tirbanibulin 1% ointment in the treatment of cancerization field: a real-life Italian multicenter observational study of 250 patients. Int J Dermatol. 2024 Apr 11
- Okhovat JP, Shumaker P, Lee KC (2022) J Am Acad Dermatol 1444-1446
- Szeimies RM (2018) Pain perception during Photodynamic Therapy - Why is Daylight PDT with MAL almost pain free? G Ital Dermatol Venereol 153:793-799
- Philipp-Dormston WG et al. (2025) Br J Dermatol. 192: 510-519. doi: 10.1093/bjd/ljae437
- Torezan L, Grinblat B, Haedersdal M et al. (2021) Eur J Dermatol 31:638-644
- Nashan D, Hüning S, Heppt MV, Brehmer A, Berking C (2020) Hautarzt 71:463-475
- Steeb T, Wessely A, Leiter U, French LE, Berking C, Heppt MV (2020) JEADV 34:727-732
- Wenande E, Bech-Thomsen N, Togsverd-Bo K, Haedersdal M (2021) Case Rep Dermatol 13:457-463